Latest Breaking News On - Dicerna pharmaceuticals inc - Page 4 : comparemela.com

Imunon (IMNN) Appoints James E Dentzer to its Board

Imunon (IMNN) Appoints James E Dentzer to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Michaelh tardugnoJamese dentzerBoard of directors curis incImunon inc nasdaqValeritas incBiogen incAmicus therapeutics incCuris incDicerna pharmaceuticals incChief executive officerCuri chief operating officerChief financialFrom marchCuri chief administrative officerChief financial officerDicerna pharmaceuticals

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

Michaelh tardugnoJamese dentzerKim sutton golodetzBoard of directors curis incJeffreyw churchBiogen incAmicus therapeutics incDicerna pharmaceuticals incCuris incExchange commissionImunon incImunon inc nasdaqValeritas incChief executive officerCuri chief operating officerChief financial

Imunon Appoints James E Dentzer to its Board of Directors

03.10.2022 - CEO of Curis brings extensive biopharmaceutical financial experience to the Board LAWRENCEVILLE, N.J., Oct. 03, 2022 (GLOBE NEWSWIRE) - Imunon, Inc. (Nasdaq: IMNN), a clinical-stage drug development company, announces the appointment of James E. . Seite 1

Michaelh tardugnoJamese dentzerBoard of directors curis incImunon inc nasdaqValeritas incBiogen incAmicus therapeutics incCuris incDicerna pharmaceuticals incChief executive officerCuri chief operating officerChief financialFrom marchCuri chief administrative officerChief financial officerDicerna pharmaceuticals

Form 424B3 Quoin Pharmaceuticals,

Form 424B3 Quoin Pharmaceuticals,
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

District of columbiaUnited statesUniversity of arizonaWharton schoolTel avivUniversity of pennsylvaniaGeorgetown universityState of israelJames culverwellDenise carterBoulder coveMerrill lynchBriana hayesJoseph cooperMichael semberGordon dunn

Terns Pharmaceuticals Reports Second Quarter 2022 Financial

TERN-701 (allosteric BCR-ABL inhibitor) advances into Phase 1 trial for CML in ChinaIND-enabling activities for TERN-601 (GLP-1R agonist) remain on track;.

Canaccord genuitySen sundaramRadhika tripuraneniKerry russellTerns pharmaceuticals incCompany nasdaqCompany board of directorsHansoh pharmaceutical group company limitedTerns pharmaceuticalsDicerna pharmaceuticals incDevelopment rd expensesYale university school of medicineProthena corporationChief development officerTerns boardChief medical officer